AKT1 and cancer: It was recently identified as a potential anti-cancer which inhibits PI3k-Akt, ERK/MAPK and Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathways involved in cell survival, proliferation, invasion and drug resistance [103].